Literature DB >> 6118453

Characterization of beta-adrenoceptors in the dog saphenous vein.

T Tokudome, N Taira.   

Abstract

In vitro experiments were carried out on strips of the dog saphenous vein to characterize beta-adrenoceptors mediating relaxation. Four beta-adrenoceptor agonists, isoproterenol, salbutamol, procaterol and alpha-(3,4,5-trimethoxyphenethylaminomethyl)-3,4-dihydroxybenzylalcohol hydrochloride (T-1583), all produced concentration-dependent relaxation of venous strips contracted by 10(-6) M methoxamine. These four drugs behaved as full agonists. In producing venous relaxation, procaterol was about 2.5 times more potent, and salbutamol and T-1583 were 7 and 98 times less potent than isoproterenol, on a molar basis. The concentration-relaxation response curves to the four agonists were shifted in a parallel way to the right by (t-butyl-amino-3-ol-2-propyl)oximino-9 fluorene hydrochloride (IPS 339), a selective beta 2-adrenoceptor antagonist, and by practolol. However, pA2-values for IPS 339 against the four agonists were all nearly 11.0, whereas those for practolol were all nearly 5.7. We conclude that beta-adrenoceptors in the dog saphenous vein mediating relaxation are predominantly on the beta 2 type.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6118453     DOI: 10.1254/jjp.31.731

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  3 in total

1.  T-1583 and forskolin are similar in their cardiac effects and dissimilar in their vascular effects.

Authors:  M Hosono; K Satoh; N Taira
Journal:  Cardiovasc Drugs Ther       Date:  1988-07       Impact factor: 3.727

2.  The inhibitory effects of iberiotoxin and 4-aminopyridine on the relaxation induced by beta 1- and beta 2-adrenoceptor activation in rat aortic rings.

Authors:  N Satake; M Shibata; S Shibata
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

3.  Human myocardial beta-adrenoceptors: demonstration of both beta 1- and beta 2-adrenoceptors mediating contractile responses to beta-agonists on the isolated right atrium.

Authors:  H R Zerkowski; K Ikezono; N Rohm; J C Reidemeister; O E Brodde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-02       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.